Christopher Posner - Net Worth and Insider Trading

Christopher Posner Net Worth

The estimated net worth of Christopher Posner is at least $75,929 dollars as of 2024-12-27. Christopher Posner is the PRESIDENT AND CEO of Cara Therapeutics Inc and owns about 168,768 shares of Cara Therapeutics Inc (CARA) stock worth over $75,929. Details can be seen in Christopher Posner's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Posner has not made any transactions after 2024-11-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Christopher Posner

To

Christopher Posner Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher Posner owns 2 companies in total, including Cara Therapeutics Inc (CARA) , and Zevra Therapeutics Inc (ZVRA) .

Click here to see the complete history of Christopher Posner’s form 4 insider trades.

Insider Ownership Summary of Christopher Posner

Ticker Comapny Transaction Date Type of Owner
CARA Cara Therapeutics Inc 2024-11-04 director
ZVRA Zevra Therapeutics Inc 2022-11-28 director

Christopher Posner Latest Holdings Summary

Christopher Posner currently owns a total of 1 stock. Christopher Posner owns 168,768 shares of Cara Therapeutics Inc (CARA) as of November 4, 2024, with a value of $75,929.

Latest Holdings of Christopher Posner

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CARA Cara Therapeutics Inc 2024-11-04 168,768 0.45 75,929

Holding Weightings of Christopher Posner


Christopher Posner Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher Posner has made a total of 14 transactions in Cara Therapeutics Inc (CARA) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in Cara Therapeutics Inc is the sale of 3,668 shares on November 4, 2024, which brought Christopher Posner around $1,064.

Insider Trading History of Christopher Posner

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher Posner Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher Posner Ownership Network

Ownership Network List of Christopher Posner

No Data

Ownership Network Relation of Christopher Posner

Insider Network Chart

Christopher Posner Owned Company Details

What does Cara Therapeutics Inc do?

Who are the key executives at Cara Therapeutics Inc?

Christopher Posner is the director of Cara Therapeutics Inc. Other key executives at Cara Therapeutics Inc include Chief Medical Officer Joana Goncalves , Sec'y; Chief Compliance & G.C. Scott Terrillion , and VP-Research & Development Menzaghi Frederique Ph.d. .

Cara Therapeutics Inc (CARA) Insider Trades Summary

Over the past 18 months, Christopher Posner made 7 insider transaction in Cara Therapeutics Inc (CARA) with a net sale of 60,412. Other recent insider transactions involving Cara Therapeutics Inc (CARA) include a net sale of 2,753 shares made by Joana Goncalves , a net sale of 2,753 shares made by Scott Terrillion ,

In summary, during the past 3 months, insiders sold 3,668 shares of Cara Therapeutics Inc (CARA) in total and bought 0 shares, with a net sale of 3,668 shares. During the past 18 months, 65,918 shares of Cara Therapeutics Inc (CARA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 65,918 shares.

Cara Therapeutics Inc (CARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cara Therapeutics Inc Insider Transactions

No Available Data

Christopher Posner Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher Posner. You might contact Christopher Posner via mailing address: C/o Cara Therapeutics, Inc., 4 Stamford Plaza, 107 Elm Street, 9th Fl, Stamford Ct 06902.

Discussions on Christopher Posner

No discussions yet.